Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
about
Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia.Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.The role of allogeneic transplantation in high-risk acute myelogenous leukemia.Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensusEffect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR.Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype.Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
P2860
Q33611146-6B28DDF7-BAC4-43E4-BD8F-EE151501E65BQ34316852-C21BE1E6-9D02-4846-9CB1-30179BF008A9Q35850703-45A333D0-3E42-4A3D-9F04-BFA9B158396DQ35887901-F41DFEF7-6035-4846-B10C-44B5D02A44AAQ35903540-E99CB1F0-5AE4-4B01-96BF-6B96DA6AC682Q38106983-57C7FF8B-B325-4DC6-BC9F-1E3BD9E2077EQ38657161-BC251E30-A5C4-4FBE-B115-B23385FD175AQ40183293-3650926D-8134-4D52-89BD-3A2D4056FEC4Q43198291-2E822488-FBB4-4873-97B0-1963E730A075Q45774394-D5B36FB2-1515-4C5C-A8CC-504761510EEDQ46216906-890FE0B4-177F-43BD-98FA-1815D29BCC7FQ46600591-6A99FC03-26A2-44D1-925B-D66FBBCABA50
P2860
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Influence of cytogenetic abnor ...... a in first complete remission.
@en
Influence of cytogenetic abnor ...... a in first complete remission.
@nl
type
label
Influence of cytogenetic abnor ...... a in first complete remission.
@en
Influence of cytogenetic abnor ...... a in first complete remission.
@nl
prefLabel
Influence of cytogenetic abnor ...... a in first complete remission.
@en
Influence of cytogenetic abnor ...... a in first complete remission.
@nl
P2093
P1476
Influence of cytogenetic abnor ...... ia in first complete remission
@en
P2093
Cynthia L Toze
Donna E Hogge
Douglas E Horsman
Eibhlin A Conneally
Heathe J Sutherland
Janet Nitta
John D Shepherd
Michael J Barnett
Stephen H Nantel
Thomas J Nevill
P304
P356
10.1053/BBMT.2002.V8.PM12234169
P577
2002-01-01T00:00:00Z